Skip to main content
Livermore
Livermore
ZHEN

Baker Bros. Advisors LP

SEC CIK
0001263508
Latest filing
Aug 14, 2026

PRLD holding history

Prelude Therapeutics Inc in every 13F filed by Baker Bros. Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PRLD overviewAll 13F holders of PRLDFull Q2 2026 holdings

Shares (Q2 2026)
10,123,824
Value
$54.0M
% of portfolio
0.3%
Quarters held
22
Since Q1 2021
Holdings of PRLD by Baker Bros. Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202610,123,824$54.0M0.3%00.0%UnchangedHolders
Q1 202610,123,824$34.6M0.2%00.0%UnchangedHolders
Q4 202510,123,824$29.4M0.2%00.0%UnchangedHolders
Q3 202510,123,824$14.6M0.1%00.0%UnchangedHolders
Q2 202510,123,824$8.19M0.1%00.0%UnchangedHolders
Q1 202510,123,824$7.78M0.1%00.0%UnchangedHolders
Q4 202410,123,824$12.9M0.1%00.0%UnchangedHolders
Q3 202410,123,824$21.0M0.2%00.0%UnchangedHolders
Q2 202410,123,824$38.6M0.5%00.0%UnchangedHolders
Q1 202410,123,824$48.0M0.6%00.0%UnchangedHolders
Q4 202310,123,824$43.2M0.5%00.0%UnchangedHolders
Q3 202310,123,824$31.3M0.2%00.0%UnchangedHolders
Q2 202310,123,824$45.6M0.3%00.0%UnchangedHolders
Q1 202310,123,824$57.7M0.3%00.0%UnchangedHolders
Q4 202210,123,824$61.1M0.4%00.0%UnchangedHolders
Q3 202210,123,824$66.9M0.4%00.0%UnchangedHolders
Q2 202210,123,824$52.8M0.3%00.0%UnchangedHolders
Q1 202210,123,824$69.9M0.4%00.0%UnchangedHolders
Q4 202110,123,824$126.0M0.6%00.0%UnchangedHolders
Q3 202110,123,824$316.4M1.4%00.0%UnchangedHolders
Q2 202110,123,824$289.8M1.3%00.0%UnchangedHolders
Q1 202110,123,824$438.7M1.9%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.